4.7 Article

Circulating intact and cleaved forms of the urokinase-type plasminogen activator receptor: Biological variation, reference intervals and clinical useful cut-points

Journal

CLINICA CHIMICA ACTA
Volume 439, Issue -, Pages 84-90

Publisher

ELSEVIER
DOI: 10.1016/j.cca.2014.10.004

Keywords

Cancer biomarker; Urokinase receptor; Reference intervals; Age- and gender-dependent variation; Colorectal cancer; Time-resolved fluorescence immunoassay

Funding

  1. Danish Cancer society [R40-A1771-11-S2]
  2. Axel Muusfeldt Foundation
  3. Copenhagen University Hospital [140382-XXXX/632-01]
  4. Lundbeck Foundation [R54-A5392]
  5. Aase and Ejnar Danielsen Fund
  6. Aage and Johanne Louis-Hansen Fund
  7. Walter and O. Kristiane Christensen Fund
  8. Sophus and Astrid Jacobsen Fund
  9. Arvid Nilsson Fund
  10. Glunz and Jensen Fund
  11. Friedrich and Else Boehm Fund
  12. Agnes and Poul Friis Fund
  13. Eva and Henry Fraenkel Fund
  14. Hartmann Bros. Fund
  15. Willy and Ingeborg Reinhard Fund
  16. Katrine and Vigo Skovgaard Fund
  17. Oda and Hans Svenningsen Fund
  18. Einar Willumsen Fund
  19. Kornerup Fund

Ask authors/readers for more resources

Background: High levels of circulating forms of the urokinase-type plasminogen activator receptor (uPAR) are significantly associated to poor prognosis in cancer patients. Our aim was to determine biological variations and reference intervals of the uPAR forms in blood, and in addition, to test the clinical relevance of using these as cut-points in colorectal cancer (CRC) prognosis. Methods: uPAR forms were measured in citrated and EDTA plasma samples using time-resolved fluorescence immunoassays. Diurnal, intra- and inter-individual variations were assessed in plasma samples from cohorts of healthy individuals. Reference intervals were determined in plasma from healthy individuals randomly selected from a Danish multi-center cross-sectional study. A cohort of CRC patients was selected from the same cross-sectional study. Results: The reference intervals showed a slight increase with age and women had -similar to 20% higher levels. The intra- and inter-individual variations were similar to 10% and similar to 20-30%, respectively and the measured levels of the uPAR forms were within the determined 95% reference intervals. No diurnal variation was found. Applying the normal upper limit of the reference intervals as cut-point for dichotomizing CRC patients revealed significantly decreased overall survival of patients with levels above this cut-point of any uPAR form. Conclusions: The reference intervals for the different uPAR forms are valid and the upper normal limits are clinically relevant cut-points for CRC prognosis. (C) 2014 Elsevier B.V. All rights reserved.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.7
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

Article Oncology

The Prognostic and Predictive Value of Soluble Type IV Collagen in Colorectal Cancer: A Retrospective Multicenter Study

Hans Christian Rolff, Ib Jarle Christensen, Ben Vainer, Lars Bo Svendsen, Rikke Lovendahl Eefsen, Michael Wilhelmsen, Ida Katrine Lund, Gunilla Hoyer-Hansen, Hans Jorgen Nielsen, Martin Illemann

CLINICAL CANCER RESEARCH (2016)

Article Gastroenterology & Hepatology

Metagenomic analysis of faecal microbiome as a tool towards targeted non-invasive biomarkers for colorectal cancer

Jun Yu, Qiang Feng, Sunny Hei Wong, Dongya Zhang, Qiao Yi Liang, Youwen Qin, Longqing Tang, Hui Zhao, Jan Stenvang, Yanli Li, Xiaokai Wang, Xiaoqiang Xu, Ning Chen, William Ka Kei Wu, Jumana Al-Aama, Hans Jorgen Nielsen, Pia Kiilerich, Benjamin Anderschou Holbech Jensen, Tung On Yau, Zhou Lan, Huijue Jia, Junhua Li, Liang Xiao, Thomas Yuen Tung Lam, Siew Chien Ng, Alfred Sze-Lok Cheng, Vincent Wai-Sun Wong, Francis Ka Leung Chan, Xun Xu, Huanming Yang, Lise Madsen, Christian Datz, Herbert Tilg, Jian Wang, Nils Brunner, Karsten Kristiansen, Manimozhiyan Arumugam, Joseph Jao-Yiu Sung, Jun Wang

Article Biochemistry & Molecular Biology

Urokinase receptor cleavage correlates with tumor volume in a transgenic mouse model of breast cancer

Tine Thurison, Kasper Almholt, Henrik Gardsvoll, Michael Ploug, Gunilla Hoyer-Hansen, Ida K. Lund

MOLECULAR CARCINOGENESIS (2016)

Article Gastroenterology & Hepatology

Increased serological cancer-associated biomarker levels at large bowel endoscopy and risk of subsequent primary cancer

Martin H. Hvolris, Thomas B. Piper, Emilie Hammer, Lars N. Jorgensen, Jesper Olsen, Hans B. Rahr, Knud T. Nielsen, Soren Laurberg, Ib J. Christensen, Nils Brunner, Julia S. Johansen, Gerard J. Davis, Barry L. Dowell, Hans J. Nielsen

SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY (2016)

Editorial Material Gastroenterology & Hepatology

Increased serological cancer-associated biomarkers and risk of development of primary malignancy after large bowel endoscopy

Hans Jorgen Nielsen

SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY (2016)

Article Oncology

TIMP-1 is under regulation of the EGF signaling axis and promotes an aggressive phenotype in KRAS-mutated colorectal cancer cells: A potential novel approach to the treatment of metastatic colorectal cancer

Line S. Tarpgaard, Maj Sofie Orum-Madsen, Ib J. Christensen, Cathrine Nordgaard, Julie Noer, Tormod K. Guren, Bengt Glimelius, Halfdan Sorbye, Tone Ikdahl, Elin H. Kure, Kjell M. Tveit, Hans J. Nielsen, Per Pfeiffer, Nils Brunner, Jose M. A. Moreira

ONCOTARGET (2016)

Article Oncology

Detection of colorectal neoplasia: Combination of eight blood-based, cancer-associated protein biomarkers

Michael Wilhelmsen, Ib J. Christensen, Louise Rasmussen, Lars N. Jorgensen, Mogens R. Madsen, Jesper Vilandt, Thore Hillig, Michael Klaeke, Knud T. Nielsen, Soren Laurberg, Nils Brunner, Susan Gawel, Xiaoqing Yang, Gerard Davis, Annemieke Heijboer, Frans Martens, Hans J. Nielsen

INTERNATIONAL JOURNAL OF CANCER (2017)

Article Gastroenterology & Hepatology

Serological biomarkers in triage of FIT-positive subjects?

Hans J. Nielsen, Ib Jarle Christensen, Berit Andersen, Morten Rasmussen, Lennart J. Friis-Hansen, Thomas Bygott, Jake MiCallef

SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY (2017)

Article Cell Biology

Direct detection of early-stage cancers using circulating tumor DNA

Jillian Phallen, Mark Sausen, Vilmos Adleff, Alessandro Leal, Carolyn Hruban, James White, Valsamo Anagnostou, Jacob Fiksel, Stephen Cristiano, Eniko Papp, Savannah Speir, Thomas Reinert, Mai-Britt Worm Orntoft, Brian D. Woodward, Derek Murphy, Sonya Parpart-Li, David Riley, Monica Nesselbush, Naomi Sengamalay, Andrew Georgiadis, Qing Kay Li, Mogens Rorbk Madsen, Frank Viborg Mortensen, Joost Huiskens, Cornelis Punt, Nicole van Grieken, Remond Fijneman, Gerrit Meijer, Hatim Husain, Robert B. Scharpf, Luis A. Diaz, Sian Jones, Sam Angiuoli, Torben Orntoft, Hans Jorgen Nielsen, Claus Lindbjerg Andersen, Victor E. Velculescu

SCIENCE TRANSLATIONAL MEDICINE (2017)

Article Biochemical Research Methods

Discovery and validation of a colorectal cancer classifier in a new blood test with improved performance for high-risk subjects

Lisa J. Croner, Roslyn Dillon, Athit Kao, Stefanie N. Kairs, Ryan Benz, Ib J. Christensen, Hans J. Nielsen, John E. Blume, Bruce Wilcox

CLINICAL PROTEOMICS (2017)

Article Oncology

Genomic alterations accompanying tumour evolution in colorectal cancer: tracking the differences between primary tumours and synchronous liver metastases by whole-exome sequencing

M. B. Mogensen, M. Rossing, O. Ostrup, P. N. Larsen, P. J. Heiberg Engel, L. N. Jorgensen, E. V. Hogdall, J. Eriksen, P. Ibsen, P. Jess, M. Grauslund, H. J. Nielsen, F. C. Nielsen, B. Vainer, K. Osterlind

BMC CANCER (2018)

Article Oncology

Triage for selection to colonoscopy?

Mathias Mertz-Petersen, Thomas B. Piper, Jakob Kleif, Linnea Ferm, Ib Jarle Christensen, Hans J. Nielsen

Article Oncology

Biomarkers for Early Detection of Colorectal Cancer: The Early Detection Research Network, a Framework for Clinical Translation

Robert S. Bresalier, William M. Grady, Sanford D. Markowitz, Hans Jorgen Nielsen, Surinder K. Batra, Paul D. Lampe

CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION (2020)

Article Oncology

Clinical Implications of Monitoring Circulating Tumor DNA in Patients with Colorectal Cancer

Lone V. Scholer, Thomas Reinert, Mai-Britt W. Orntoft, Christine G. Kassentoft, Sigrid S. Arnadottir, Soren Vang, Iver Nordentoft, Michael Knudsen, Philippe Lamy, Ditte Andreasen, Frank V. Mortensen, Anders R. Knudsen, Katrine Stribolt, Kim Sivesgaard, Peter Mouritzen, Hans J. Nielsen, Soren Laurberg, Torben F. Orntoft, Claus L. Andersen

CLINICAL CANCER RESEARCH (2017)

Article Cell Biology

miRNA profiling of circulating EpCAM(+) extracellular vesicles: promising biomarkers of colorectal cancer

Marie Stampe Ostenfeld, Steffen Grann Jensen, Dennis Kjolhede Jeppesen, Lise-Lotte Christensen, Stine Buch Thorsen, Jan Stenvang, Michael Lykke Hvam, Anni Thomsen, Peter Mouritzen, Mads Heilskov Rasmussen, Hans Jorgen Nielsen, Torben Falck Orntoft, Claus Lindbjerg Andersen

JOURNAL OF EXTRACELLULAR VESICLES (2016)

Article Medical Laboratory Technology

Clinical and genetic analysis of 26 Chinese patients with neonatal intrahepatic cholestasis due to citrin deficiency

Jiansheng Lin, Weihua Lin, Yiming Lin, Weilin Peng, Zhenzhu Zheng

Summary: This study retrospectively analyzed the cases of Chinese infants with NICCD and identified multiple genetic mutations. The study also found comorbidity of NICCD and other inborn errors of metabolism in some patients.

CLINICA CHIMICA ACTA (2024)

Review Medical Laboratory Technology

M-protein detection by mass spectrometry for minimal residual disease in multiple myeloma

Lihua Guan, Wei Su, Jian Zhong, Ling Qiu

Summary: Multiple myeloma is characterized by excessive production of monoclonal immunoglobulins. Routine screening methods are insufficient for detecting low levels of M proteins, but advances in mass spectrometry enable reliable detection of low abundance serum biomarkers for minimal residual disease assessment in multiple myeloma.

CLINICA CHIMICA ACTA (2024)

Article Medical Laboratory Technology

Identification of an association between coronary heart disease and ITGB2 methylation in peripheral blood by a case-control study

Liya Zhu, Chao Zhu, Jialie Jin, Jinxin Wang, Xiaojing Zhao, Rongxi Yang

Summary: This study found an association between blood-based ITGB2 methylation and coronary heart disease (CHD), with hypomethylation of ITGB2 being a risk factor for CHD. Additionally, the combination of ITGB2 methylation and conventional CHD risk factors could efficiently discriminate CHD patients from controls.

CLINICA CHIMICA ACTA (2024)

Article Medical Laboratory Technology

The impact of saliva collection methods on measured salivary biomarker levels

H. Al Habobe, E. B. Haverkort, K. Nazmi, A. P. Van Splunter, R. H. H. Pieters, F. J. Bikker

Summary: Saliva diagnostics have become popular due to their non-invasive nature and patient-friendly collection process. However, the choice of saliva collection method can affect the measured levels of various biomarkers.

CLINICA CHIMICA ACTA (2024)

Article Medical Laboratory Technology

Sex-related differences in within-subject biological variation estimates for 22 essential and non-essential amino acids

Abdurrahman Coskun, Anna Carobene, Ozlem Demirelce, Michele Mussap, Federica Braga, Ebru Sezer, Aasne Karine Aarsand, Sverre Sandberg, Pilar Fernandez Calle, Jorge Diaz-Garzon, Metincan Erkaya, Cihan Coskun, Esila Nur Erol, Hunkar Dag, Bill Bartlett, Mustafa Serteser, Niels Jonker, Ibrahim Unsal

Summary: In this study, BV estimates for 22 AAs were provided based on a large sample size, and it was found that there are differences in CVI estimates between males and females for most AAs, which has implications for the clinical interpretation and use of AAs.

CLINICA CHIMICA ACTA (2024)

Review Medical Laboratory Technology

Genomic profile of Parkinson's disease in Asians

Valentinus Besin, Farizky Martriano Humardani, Trilis Yulianti, Matthew Justyn

Summary: The study of Parkinson's Disease in Asian populations has revealed the impact of genetic variants on multiple biological pathways and highlighted shared genetic susceptibility with other diseases. These findings emphasize the importance of personalized treatment based on individual genetic profiles.

CLINICA CHIMICA ACTA (2024)

Review Medical Laboratory Technology

Prediction of atherosclerotic cardiovascular risk in early childhood

Simona Ferraro, Sara Benedetti, Savina Mannarino, Santica Marcovina, Elia Mario Biganzoli, Gianvincenzo Zuccotti

Summary: Risk stratification for cardio-vascular disease should be implemented in childhood to promote early prevention strategies, as atherosclerotic lesions can be present even in very young individuals. Evaluating pediatric CV risk factors/clinical conditions and conducting lipid profile and genetic testing can help identify children at risk of future CV events and guide appropriate therapeutic options.

CLINICA CHIMICA ACTA (2024)

Review Medical Laboratory Technology

Advances in human reproductive biomarkers

Ahmad Mobed, Bita Abdi, Sajjad Masoumi, Mohammad Mikaeili, Elham Shaterian, Hamed Shaterian, Esmat Sadat Kazemi, Mahdiye Shirafkan

Summary: Reproductive biomarkers play important regulatory roles in women. The discovery and quantification of these biomarkers are clinically significant. Various detection strategies, including nanotechnology-based methods, have been developed. This article provides an in-depth introduction to the latest advances in biosensor and nanosensor research for detecting and quantitatively identifying reproductive biomarkers.

CLINICA CHIMICA ACTA (2024)

Article Medical Laboratory Technology

A pilot study of newborn screening for X-linked adrenoleukodystrophy based on liquid chromatography-tandem mass spectrometry method for detection of C26:0-lysophosphatidylcholine in dried blood spots: Results from 43,653 newborns in a southern Chinese population

Chengfang Tang, Fang Tang, Yanna Cai, Minyi Tan, Sichi Liu, Ting Xie, Xiang Jiang, Yonglan Huang

Summary: This study proposes an effective method for screening X-ALD and evaluates the performance of newborn screening for X-ALD in Guangzhou. The LC-MS/MS method can accurately identify X-ALD through analysis of C26:0-LPC.

CLINICA CHIMICA ACTA (2024)

Article Medical Laboratory Technology

Prenatal prevalence and postnatal manifestations of 16p11.2 deletions: A new insights into neurodevelopmental disorders based on clinical investigations combined with multi-omics analysis

Lan Liu, Jiamin Wang, Xijing Liu, Jing Wang, Lin Chen, Hongmei Zhu, Jingqun Mai, Ting Hu, Shanling Liu

Summary: The 16p11.2 deletion is a common genetic cause of neurodevelopmental disorders, with prenatal and postnatal presentations including vertebral malformations and language impairment. The majority of deletions are de novo and may be associated with MAPK3 and histidine-associated metabolism.

CLINICA CHIMICA ACTA (2024)

Article Medical Laboratory Technology

Prospectives and retrospectives of microfluidics devices and lab-on-A-chip emphasis on cancer

Sneha Venkatesalu, Shanmugapriya Dilliyappan, Avanthika Satish Kumar, Thirunavukkarasu Palaniyandi, Gomathy Baskar, Maddaly Ravi, Asha Sivaji

Summary: Microfluidics is a science and technology that deals with less sample-to-more precision in vitro analysis. It has wide applications in cancer theranostics, enabling precise diagnosis and personalized treatment.

CLINICA CHIMICA ACTA (2024)

Review Medical Laboratory Technology

Genetics of congenital heart disease

Yuanqin Zhao, Wei Deng, Zhaoyue Wang, Yanxia Wang, Hongyu Zheng, Kun Zhou, Qian Xu, Le Bai, Huiting Liu, Zhong Ren, Zhisheng Jiang

Summary: The cardiovascular system and the central nervous system exhibit a coordinated developmental process during embryonic development. Congenital heart disease (CHD) is the most common congenital disorder, and neurodevelopmental disorders (NDD) are common complications in CHD patients. Both genetic and non-genetic factors contribute to the co-occurrence of CHD and NDD. Further research should focus on identifying common molecular mechanisms underlying this co-occurrence and promoting the research and treatment of developmental disorders related to the cardiovascular and central nervous systems.

CLINICA CHIMICA ACTA (2024)

Article Medical Laboratory Technology

Flow cytometry in the detection of circulating tumor cells in neoplastic effusions

Karol Gostomczyk, Ewelina Lukaszewska, Jedrzej Borowczak, Anita Bator, Marek Zdrenka, Magdalena Bodnar, Lukasz Szylberg

Summary: Flow cytometry improves the detection of epithelial cancer cells in peritoneal and pleural fluids compared to conventional cytology. Due to similar speciflcity and higher sensitivity, flow cytometry offers a promising alternative to cytology for patient screening.

CLINICA CHIMICA ACTA (2024)

Article Medical Laboratory Technology

Usability of serum inter-α-trypsin inhibitor heavy chain 4 as a biomarker for assessing severity and predicting functional outcome after human aneurysmal subarachnoid hemorrhage: A prospective observational cohort study at a single institution

Heping Tian, Genghuan Wang, Qi Zhong, Haihang Zhou

Summary: This study found that the decline of serum ITIH4 concentrations during the early phase after aneurysmal subarachnoid hemorrhage (aSAH) was closely related to the severity and poor prognosis of the disease. Serum ITIH4 may represent a promising prognostic biomarker of aSAH.

CLINICA CHIMICA ACTA (2024)

Article Medical Laboratory Technology

Accurate identification of HLA-B*15:02 allele by two-dimensional polymerase chain reaction

Xueting Zhu, Yang Yu, Jun Zhang, Yuxia Zhan, Guanghua Luo, Lu Zheng

Summary: This study successfully established a 2D-PCR method for identifying HLA-B*15:02 through a two-tube reaction. This method can distinguish HLA-B*15:02 from 16 highly homologous HLA-B*15 alleles. Among 1830 samples from the clinical general population, 3 HLA-B*15:02 homozygotes and 84 HLA-B*15:02 heterozygotes were detected.

CLINICA CHIMICA ACTA (2024)